Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Oct 12 2018

Improving Hospital Performance

By Kevin Roche Commentary No Comments
The Advisory Board issues a brief paper on how hospital quality and lower costs can go hand-in-hand.
Read More
Oct 11 2018

Latest Altarum Health Sector Spending Report

By Kevin Roche Commentary No Comments
The current quarterly Altarum Institute Health Sector Trend Report reveals moderate, for health care, spending growth.
Read More
Oct 10 2018

The Outcomes of Dedicated, At-risk Primary Care Groups

By Kevin Roche Commentary No Comments
A study in the American Journal of Managed Care finds that a high-touch primary care group delivers better outcomes for Medicare beneficiaries.
Read More
Oct 09 2018

Physician Survey, Part II

By Kevin Roche Commentary No Comments
More on physicians' attitudes about work and the health system from the Physicians Foundation biennial survey.
Read More
Oct 08 2018

Merritt Hawkins Physician Survey Part 1

By Kevin Roche Commentary No Comments
The biennial survey of doctors sponsored by the Physicians Foundation and conducted by recruiting firm Merritt Hawkins has been released.
Read More
Oct 05 2018

Willis Towers Watson on Health Benefits

By Kevin Roche Commentary No Comments
Willis Towers Watson gives us its perspective on what is happening with employment-based health benefits.
Read More
Oct 04 2018

Weight Loss Interventions

By Kevin Roche Commentary No Comments
JAMA has the latest recommendation and supporting research on behavioral interventions for weight loss.
Read More
Oct 03 2018

Provider Consolidation in California

By Kevin Roche Commentary No Comments
Provider consolidation in California has caused significant premium increases and health care service price growth, according to an analysis in Health Affairs.
Read More
Oct 02 2018

2019 Medicare Advantage Plans

By Kevin Roche Commentary No Comments
Beneficiaries will have more Medicare Advantage plan choices and experience lower premiums in 2019, according to a CMS announcement.
Read More
Oct 01 2018

Cost of Pivotal Trials for New Drugs

By Kevin Roche Commentary No Comments
An analysis in JAMA Internal Medicine suggests that the cost of drug pivotal trials may be less than what the industry suggests.
Read More
  • « Previous
  • 1
  • …
  • 394
  • 395
  • 396
  • 397
  • 398
  • …
  • 641
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

IKS Health, a British company with a US subsidiary that offers “care enablement” and mentions AI, of course,  is buying TruBridge for $557 million.  TruBridge offers revenue cycle management and...
April 30, 2026
Innovacer, which basically collects data on a patient from multiple sources and aggregates it, raised an astounding $275 million in new capital, supposedly at a valuation of almost $3.5 billion....
April 22, 2026
A company called Whoop raised a ridiculous $575 million in new capital at a supposed $10 billion valuation.  The press release was released on April 1, so I would like...
April 5, 2026
Big deals continue in health care financings.  eMed, which manages weight loss medications for employers, raises a hefty $200 million, giving it a valuation of $2 billion, which seems crazy....
March 31, 2026

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1844) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Congressional Budget Office
  • Health Affairs

RSS Feed

RSS feed

© 2026 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts